IndiaTickerPiramal Pharma Ltd - 543635 - Board Meeting Outcome for Outcome Of Board Meeting Of Piramal Pharma Limited Held On 29Th July, 2026BSE · exchange filing · pdf
Source filing Company dossier
Piramal Pharma
NSE:PPLPHARMA · ISIN INE0DK501011
- Close
- ₹195.68 29 Jul 2026
- Daily change
- N/A Exchange close
- Evidence state
- Building 0/0 checks
Piramal Pharma
Filings
Preserved evidence
40 recent eventsPrimary-source filing timeline
Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseBSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Unaudited Financial Results (Standalone & Consolidated) Of The Company For The Quarter Ended 30Th June, 2026BSE · financial results · pdf
Source filing Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Investor PresentationBSE · investor presentation · pdf
Source filing Investor Presentation - Piramal Pharma LimitedNSE · investor presentation · pdf
Source filing Outcome of Board Meeting - Piramal Pharma LimitedNSE · financial results · pdf
Source filing Press Release - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Piramal Pharma LimitedNSE · conference call · pdf
Source filing General Updates - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Regulation 30 Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Grant Of Stock OptionsBSE · exchange filing · pdf
Source filing Updates - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 - Temporary Suspension Of Operations At Company'S Facilities Located At Ahmedabad, Gujarat.BSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Board Meeting Intimation for Considering And Approving The Unaudited Financial Results (Standalone And Consolidated) Of The Company For Quarter Ended 30Th June, 2026.
BSE · financial results · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Piramal Pharma LimitedNSE · conference call · pdf
Source filing Piramal Pharma Ltd - 543635 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011BSE · exchange filing · pdf
Source filing General Updates - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Updates - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Shareholders meeting - Piramal Pharma LimitedNSE · annual report · pdf
Archived filing Piramal Pharma Ltd - 543635 - Business Responsibility and Sustainability Reporting (BRSR)BSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Notice Of The 6Th Annual General Meeting And Annual Report For The Financial Year 2025-26BSE · annual report · pdf
Archived filing Piramal Pharma Ltd - 543635 - Reg. 34 (1) Annual Report.BSE · annual report · pdf
Archived filing Disclosure under SEBI Takeover Regulations - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Trading Window - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Closure of Trading WindowBSE · exchange filing · pdf
Source filing News Verification - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Clarification On News Item Appearing On NDTV Profit Captioned - "Piramal Pharma Share Price Spikes Over 10% - What Is Driving The Rally?"BSE · exchange filing · pdf
Source filing Copy of Newspaper Publication - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Newspaper PublicationBSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSBSE · exchange filing · pdf
Source filing ESOP/ESOS/ESPS - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015BSE · exchange filing · pdf
Source filing Action(s) taken or orders passed - Piramal Pharma LimitedNSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing Analysts/Institutional Investor Meet/Con. Call Updates - Piramal Pharma LimitedNSE · conference call · pdf
Source filing Piramal Pharma Ltd - 543635 - Compliances-Reg.24(A)-Annual Secretarial ComplianceBSE · exchange filing · pdf
Source filing Piramal Pharma Ltd - 543635 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationBSE · exchange filing · pdf
Source filing